tiprankstipranks

Matthew Walls Insider Profile

4 Followers
Matthew Walls, Chief Executive Officer at Genedrive, holds 11.76M shares in GENinCode UK Ltd. (Ticker: GB:GENI), holds 1.52M shares in MyHealthChecked PLC (Ticker: GB:MHC), holds 13.77K shares in Genedrive (Ticker: GB:GDR). Most recently, Matthew Walls Bought ― shares of GENinCode UK Ltd. on Dec 22, 2023 for an estimated value of 50.00K.
tipranks
Matthew Walls

Matthew Walls
Genedrive (GDR)
Chief Executive Officer

Ranked #80,888 out of 97,944 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-28.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£947K
83.87%
16.11%
0.02%
A breakdown of Matthew Walls's holdings

Insider Roles

GENinCode UK Ltd.
(GENI)
Chief Executive Officer, Ten Percent Owner
MyHealthChecked PLC
(MHC)
Director
Genedrive
(GDR)
Chief Executive Officer
Roles that Matthew Walls holds in companies

Most Profitable Insider Trade

Stock:
GENinCode UK Ltd.
(GENI)
Rating:Informative Buy
Date:Dec 22, 2023 - Today
Return:+28.50%
The most profitable trade made by Matthew Walls

Matthew Walls's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Genedrive
Oct 15, 2015
Chief Executive Officer
Uninformative Buy
2.36K
£230.66
MyHealthChecked PLC
Apr 08, 2019
Director
Informative Buy
30.00K
£152.50K
GENinCode UK Ltd.
Dec 22, 2023
Chief Executive Officer, Ten Percent Owner
Informative Buy
50.00K
£793.97K
List of latest transactions for each holding click on a transaction to see Matthew Walls's performance on stock

Matthew Walls insider profile FAQ

What is the percentage of profitable transactions made by Matthew Walls?
The percentage of profitable transactions made by Matthew Walls is 25%.
    What is the average return per transaction made by Matthew Walls?
    The average return per transaction made by Matthew Walls is -28.10%.
      What stocks does Matthew Walls hold?
      Matthew Walls holds: GB:GDR, GB:MHC, GB:GENI stocks.
        What was Matthew Walls’s latest transaction?
        Matthew Walls latest transaction was an Informative Buy of 50.00K.
          What was Matthew Walls's most profitable transaction?
          Matthew Walls’s most profitable transaction was an Informative Buy of GB:GENI stock on December 22, 2023. The return on the trade was 28.50%.
            What is Matthew Walls's role in Genedrive?
            Matthew Walls's role in Genedrive is Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.